Severe Aplastic Anaemia Working Party (SAAWP)
Type d'étude:
Numéro de l'étude:
84090088
Type de traitement à base de cellules souches:
Maladies:
Bone marrow failure
Titre court:
RACE-2: long-term follow-up
Objectif principal:
To evaluate the long-term outcome and survival of patients who have received standard IST with or without Eltrombopag within the RACE trial.
Principaux critères d'inclusion:
Subject participated in the RACE trial (EudraCT number: 2014-000363-40) during which patient received ATGAM, Cyclosporine A with or without Eltrombopag.
Pays:
Investigateur principal:
Régis Peffault de Latour, Antonio M. Risitano
Coordinateur EBMT de l'étude:
Brian Piepenbroek
E-mail du coordinateur de l'étude:
saawpebmt@lumc.nl